466 related articles for article (PubMed ID: 26627606)
1. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
2. Liver cancer: TGF-β and cholangiocarcinoma.
Patman G
Nat Rev Gastroenterol Hepatol; 2016 Jan; 13(1):2-3. PubMed ID: 26669764
[No Abstract] [Full Text] [Related]
3. Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.
Nakagawa H; Suzuki N; Hirata Y; Hikiba Y; Hayakawa Y; Kinoshita H; Ihara S; Uchino K; Nishikawa Y; Ijichi H; Otsuka M; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Tateishi K; Koike K
Proc Natl Acad Sci U S A; 2017 May; 114(19):E3806-E3815. PubMed ID: 28439013
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
5. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.
Morris SM; Carter KT; Baek JY; Koszarek A; Yeh MM; Knoblaugh SE; Grady WM
Oncogene; 2015 Jun; 34(25):3273-82. PubMed ID: 25132272
[TBL] [Abstract][Full Text] [Related]
6. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
7. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice.
Scholten D; Osterreicher CH; Scholten A; Iwaisako K; Gu G; Brenner DA; Kisseleva T
Gastroenterology; 2010 Sep; 139(3):987-98. PubMed ID: 20546735
[TBL] [Abstract][Full Text] [Related]
8. Loss of Gab1 adaptor protein in hepatocytes aggravates experimental liver fibrosis in mice.
Kizu T; Yoshida Y; Furuta K; Ogura S; Egawa M; Chatani N; Hamano M; Takemura T; Ezaki H; Kamada Y; Nishida K; Nakaoka Y; Kiso S; Takehara T
Am J Physiol Gastrointest Liver Physiol; 2015 Apr; 308(7):G613-24. PubMed ID: 25617348
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.
Nishio M; Sugimachi K; Goto H; Wang J; Morikawa T; Miyachi Y; Takano Y; Hikasa H; Itoh T; Suzuki SO; Kurihara H; Aishima S; Leask A; Sasaki T; Nakano T; Nishina H; Nishikawa Y; Sekido Y; Nakao K; Shin-Ya K; Mimori K; Suzuki A
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E71-80. PubMed ID: 26699479
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
12. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
13. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
Yan J; Tung HC; Li S; Niu Y; Garbacz WG; Lu P; Bi Y; Li Y; He J; Xu M; Ren S; Monga SP; Schwabe RF; Yang D; Xie W
Gastroenterology; 2019 Sep; 157(3):793-806.e14. PubMed ID: 31170413
[TBL] [Abstract][Full Text] [Related]
14. Epigenomic Evaluation of Cholangiocyte Transforming Growth Factor-β Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
Aseem SO; Jalan-Sakrikar N; Chi C; Navarro-Corcuera A; De Assuncao TM; Hamdan FH; Chowdhury S; Banales JM; Johnsen SA; Shah VH; Huebert RC
Gastroenterology; 2021 Feb; 160(3):889-905.e10. PubMed ID: 33058867
[TBL] [Abstract][Full Text] [Related]
15. TGFβ signaling limits lineage plasticity in prostate cancer.
Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
[TBL] [Abstract][Full Text] [Related]
16. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
18. Prominin-1-expressing hepatic progenitor cells induce fibrogenesis in murine cholestatic liver injury.
Fenlon M; Short C; Xu J; Malkoff N; Mahdi E; Hough M; Glazier A; Lee C; Asahina K; Wang KS
Physiol Rep; 2020 Jul; 8(14):e14508. PubMed ID: 32686913
[TBL] [Abstract][Full Text] [Related]
19. Depletion of Tgfbr2 in hepatocytes alleviates liver fibrosis and restores hepatic function in fibrotic mice.
Liu SQ; Deng X; Zhu CP; Cui YL; Xie WF; Zhang X
J Dig Dis; 2023 Jan; 24(1):39-50. PubMed ID: 36967587
[TBL] [Abstract][Full Text] [Related]
20. Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
Petrescu AD; Grant S; Williams E; Frampton G; Parks N; Blaney H; Davies M; John R; Reinhart EH; McMillin M; DeMorrow S
Am J Pathol; 2020 Mar; 190(3):586-601. PubMed ID: 31953035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]